-+ 0.00%
-+ 0.00%
-+ 0.00%

Profound Medical Sees Q3 Sales $9.800M-$10.000M vs $6.934M Est

Benzinga·10/07/2026 21:30:06
Profound Medical (NASDAQ:PROF) sees Q3 sales of $9.800 million-$10.000 million vs $6.934 million analyst estimate.